Bernard Zinman is Director of the Leadership Sinai Centre for Diabetes and holds the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and the University of Toronto, Canada. He is Professor of Medicine at the University of Toronto and Senior Scientist at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Dr. Zinman was Director of the Banting and Best Diabetes Centre (1993-2000) and is involved with diabetes care and research at both national and international levels. Dr. Zinman is the Principal Investigator of the University of Toronto Centre and Vice Chair for the DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) study.
Dr. Zinman completed his medical degree at McGill University, where he also received his postgraduate training in internal medicine. He undertook further training at the University of Toronto in Endocrinology.
Dr. Zinman has authored more than 400 publications in national and international journals, and over 60 book chapters and editorials. He is the recipient of numerous awards including the Charles H. Best Medal for Distinguished Service in the Cause of Diabetes (awarded to the DCCT Investigators), the Alois Beringer Lecture Award, the Frederick G. Banting Award and the Gerald S. Wong Service Award of the Canadian Diabetes Association (CDA). In August 2003, Dr. Zinman delivered the Banting and Best Memorial Lecture at the International Diabetes Federation Congress in Paris, France. In 2006, Dr. Zinman received the American Diabetes Association's Outstanding Physician Clinician Award. In 2009, Dr. Zinman was awarded the Lifetime Achievement Award from the Canadian Diabetes Association and the Novartis Prize in Diabetes and in 2010, he delivered the Charles H. Best Lecture at the Toronto Diabetes Association's Annual Scientific Meeting. Most recently, in December 2011, Dr. Zinman was appointed to the Order of Canada, in recognition of his achievements in diabetes patient care and research.
His main research interests include the long-term complications of diabetes mellitus, the development of new therapies for Type 1 and Type 2 diabetes, diabetes in Aboriginal communities, and studies directed at the prevention of diabetes.